Selenocysteine derivative overcomes TRAIL resistance in melanoma cells: evidence for ROS-dependent synergism and signaling crosstalk
Wenqiang Cao(Jinan University), Tianfeng Chen(Ministry of Education)
Cited by 30
Related Papers
Decorated ultrathin bismuth selenide nanosheets as targeted theranostic agents for in vivo imaging guided cancer radiation therapy
|NPG Asia Materials|2017|87
Ruthenium Polypyridyl Complex Inhibits Growth and Metastasis of Breast Cancer Cells by Suppressing FAK signaling with Enhancement of TRAIL-induced Apoptosis
|Scientific Reports|2015|70
Bioinspired tumor-homing nanosystem for precise cancer therapy via reprogramming of tumor-associated macrophages
|NPG Asia Materials|2018|60
Biomedical Application of Reactive Oxygen Species–Responsive Nanocarriers in Cancer, Inflammation, and Neurodegenerative Diseases
|Frontiers in Chemistry|2020|55
Chiral Selenium Nanotherapeutics Regulates Selenoproteins to Attenuate Glucocorticoid‐Induced Osteoporosis
|Advanced Functional Materials|2023|52